ARCHIVES

DCT Board Approves New RFA For Aids Clinical Trials Groups

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

In Brief CCOP Prospects Submit 130 Letters Of Intent; DeVita recovering On Schedule from Surgery

September 26, 1986

8 Centers Awarded Comprehensive Designation

February 15, 1991

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

Clinical Trials Approved By NCI

November 26, 2010

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996